Pitcairn Co

SEC CIK: 0000315014
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by Pitcairn Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overview All 13F holders of RXRX Full Q2 2026 holdings

Shares (Q4 2023): 0; Sold out in Q4 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2023

Holdings of RXRX by Pitcairn Co, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2023	0	$0	0.0%	−11,745−100.0%	Sold out	Holders
Q3 2023	11,745	$89.8K	<0.1%	−18−0.2%	Reduced	Holders
Q2 2023	11,763	$87.9K	<0.1%	+11,763	New	Holders